GSK/Par Paxil Generic Deal Upheld In Court; FTC Closes Patent Investigation
Executive Summary
GlaxoSmithKline's "authorized" generic Paxil agreement with Par does not raise any antitrust concerns, Chicago federal court Judge Richard Posner ruled Oct. 29